Back
Reshape Lifesciences Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
27
RSLS
Reshape Lifesciences
Last Price:
$6.30
Seasonality Move:
-22.75%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RSLS is experiencing slight buying pressure.
Reshape Lifesciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.41 | Sell |
| 20-day SMA: | 8.52 | Sell |
| 50-day SMA: | 12.17 | Sell |
| 200-day SMA: | 112.3 | Sell |
| 8-day EMA: | 7.06 | Sell |
| 20-day EMA: | 8.72 | Sell |
| 50-day EMA: | 19.04 | Sell |
| 200-day EMA: | 280.09 | Sell |
Reshape Lifesciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.29 | Sell |
| Relative Strength Index (14 RSI): | 37.74 | Sell |
| Chaikin Money Flow: | 2053 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.11 - 10.85) | Sell |
| Bollinger Bands (100): | (4.17 - 92.07) | Sell |
Reshape Lifesciences Technical Analysis
| May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reshape Lifesciences Stock
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 5.98 while RSLS 8-day simple moving average is 7.41, which is a Sell signal.
-
The stock price of RSLS is 5.98 while Reshape Lifesciences 20-day SMA is 8.52, which makes it a Sell.
-
Reshape Lifesciences 50-day simple moving average is 12.17 while RSLS share price is 5.98, making it a Sell technically.
-
RSLS stock price is 5.98 and Reshape Lifesciences 200-day simple moving average is 112.30, creating a Sell signal.
RSLS Technical Analysis vs Fundamental Analysis
Sell
27
Reshape Lifesciences (RSLS)
is a Sell
Is Reshape Lifesciences a Buy or a Sell?
-
Reshape Lifesciences stock is rated a SellThe current Reshape Lifesciences [RSLS] share price is $5.98. The Score for RSLS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Reshape Lifesciences Stock Info
Market Cap:
2.7M
Price in USD:
5.98
Share Volume:
35.9K
Reshape Lifesciences 52-Week Range
52-Week High:
725.02
52-Week Low:
5.53
Sell
27
Reshape Lifesciences (RSLS)
is a Sell
Reshape Lifesciences Share Price Forecast
-
What is the Reshape Lifesciences stock price today?The Reshape Lifesciences stock price is 5.98 USD today.
-
Will RSLS stock go up or go down?Reshape Lifesciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Reshape Lifesciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reshape Lifesciences is overvalued.
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 5.98 while RSLS 8-day exponential moving average is 7.06, which is a Sell signal.
-
The stock price of RSLS is 5.98 while Reshape Lifesciences 20-day EMA is 8.72, which makes it a Sell.
-
Reshape Lifesciences 50-day exponential moving average is 19.04 while RSLS share price is 5.98, making it a Sell technically.
-
RSLS stock price is 5.98 and Reshape Lifesciences 200-day simple moving average is 280.09, creating a Sell signal.
Fundamental Analysis of Reshape Lifesciences
Is Reshape Lifesciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Reshape Lifesciences
Should I short Reshape Lifesciences stock?
-
RSLS Moving Average Covergence Divergence (MACD) indicator is -2.29, suggesting Reshape Lifesciences is a Sell
-
Reshape Lifesciences Relative Strength Index (RSI) is 37.74, which suggest Reshape Lifesciences is oversold
-
The Bollinger Bands (25) for Reshape Lifesciences is (7.11 - 10.85), which suggest Reshape Lifesciences is a Sell
-
The Bollinger Bands (100) for Reshape Lifesciences is (4.17 - 92.07), which suggest Reshape Lifesciences is a Sell
* Reshape Lifesciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.